Concepedia

Carolina Sturm

CS

Statistics

Publications

4

Citations

82

H-Index

4

Active since

2015

Affiliations

Roche (Switzerland)(Current)

Doctors Company (United States)

Roche (United States)

Restaurant Opportunities Centers United

Reckitt Benckiser (United States)

Carolina Sturm is an author at Roche (Switzerland) specializing in pharmacology, anaplastic lymphoma kinase inhibitors, and alk inhibition.

Publications per year

2015–2017

4

Publications

4

Effect of Food and Esomeprazole on the Pharmacokinetics of Alectinib, a Highly Selective ALK Inhibitor, in Healthy Subjects

Peter N. Morcos, Elena Guerini, Neil Parrott et al. · Clinical Pharmacology in Drug Development · 2016 · 47 citations

Medicine, Pharmacokinetics, Pharmacology +14

Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study

Dietmar Schwab, Carolina Sturm, Agnès Portron et al. · BMJ Open Ophthalmology · 2017 · 14 citations · Full text

Medicine, Ophthalmology, Pharmacology +15

3101 Updated efficacy and safety results from a global phase 2, open-label, single-arm study (NP28673) of alectinib in crizotinib-refractory ALK+ non-small-cell lung cancer (NSCLC)

Fabrice Barlési, Anne‐Marie C. Dingemans, I. Ou et al. · European Journal of Cancer · 2015 · 11 citations

Medicine, Oncology, Pharmacology +16

Effect of the Wetting Agent Sodium Lauryl Sulfate on the Pharmacokinetics of Alectinib: Results From a Bioequivalence Study in Healthy Subjects

Peter N. Morcos, Neil Parrott, Ludger Banken et al. · Clinical Pharmacology in Drug Development · 2016 · 10 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

1–4 of 4